Cannabidiol hydroxyquinone-induced apoptosis of splenocytes is mediated predominantly by thiol depletion

Toxicology Letters

Volumn 195, Issue 1, 2010, Pages 68-74

  Wu, Hsin Ying ^a   Jan, Tong Rong ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cannabidiol hydroxyquinone; HU 331; Splenocyte; Thiol

Indexed keywords

ACETYLCYSTEINE; CANNABIDIOL HYDROXYQUINONE; CASPASE 8; CATALASE; GLUTATHIONE; HYDROGEN PEROXIDE; PYRUVIC ACID; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; THIOL; THIORPHAN; UNCLASSIFIED DRUG; CANNABIDIOL; DRUG DERIVATIVE; THIOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; MALE; METABOLITE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; LYMPHOCYTE; METABOLISM; SPLEEN;

ANIMALS; APOPTOSIS; CANNABIDIOL; CASPASE 8; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; SPLEEN; SULFHYDRYL COMPOUNDS;

EID: 77951897515     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.02.012     Document Type: Article

References (37)

1. Biswas S., Chida A.S., Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem. Pharmacol. 2006, 71:551-564.
2. Bornheim L.M., Grillo M.P. Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. Chem. Res. Toxicol. 1998, 11:1209-1216.
3. 2 generation and topoisomerase II inhibition. Free Radic. Biol. Med. 2008, 45:627-635.
4. Circu M.L., Aw T.Y. Glutathione and apoptosis. Free Radic. Res. 2008, 42:689-706.
5. Costa B., Trovato A.E., Comelli F., Giagnoni G., Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur. J. Pharmacol. 2007, 556:75-83.
6. Davis W., Ronai Z., Tew K.D. Cellular thiols and reactive oxygen species in drug-induced apoptosis. J. Pharmacol. Exp. Ther. 2001, 296:1-6.
7. Dey A., Yadav S., Dhawan A., Seth P.K., Parmar D. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes. Life Sci. 2006, 79:1729-1735.
8. Friesen C., Fulda S., Debatin K.M. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ. 1999, 6:471-480.
9. Gouaze V., Mirault M.E., Carpentier S., Salvayre R., Levade T., Andrieu-Abadie N. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol. Pharmacol. 2001, 60:488-496.
10. Hodges V.M., Molloy G.Y., Wickramasinghe S.N. Demonstration of mRNA for five species of cytochrome P450 in human bone marrow, bone marrow-derived macrophages and human haemopoietic cell lines. Br. J. Haematol. 2000, 108:151-156.
11. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 1995, 35:607-634.
12. Huang H.L., Fang L.W., Lu S.P., Chou C.K., Luh T.Y., Lai M.Z. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 2003, 22:8168-8177.
13. Jan T.R., Su S.T., Wu H.Y., Liao M.H. Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice. Int. Immunopharmacol. 2007, 7:773-780.
14. Kalivendi S.V., Konorev E.A., Cunningham S., Vanamala S.K., Kaji E.H., Joseph J., Kalyanaraman B. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem. J. 2005, 389:527-539.
15. Kaminski N.E., Koh W.S., Yang K.H., Lee M., Kessler F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 1994, 48:1899-1908.
16. Kim H.J., Nel A.E. The role of phase II antioxidant enzymes in protecting memory T cells from spontaneous apoptosis in young and old mice. J. Immunol. 2005, 175:2948-2959.
17. Kogan N.M., Blazquez C., Alvarez L., Gallily R., Schlesinger M., Guzman M., Mechoulam R. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. Mol. Pharmacol. 2006, 70:51-59.
18. Kogan N.M., Rabinowitz R., Levi P., Gibson D., Sandor P., Schlesinger M., Mechoulam R. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. J. Med. Chem. 2004, 47:3800-3806.
19. Kogan N.M., Schlesinger M., Peters M., Marincheva G., Beeri R., Mechoulam R. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study. J. Pharmacol. Exp. Ther. 2007, 322:646-653.
20. Kogan N.M., Schlesinger M., Priel E., Rabinowitz R., Berenshtein E., Chevion M., Mechoulam R. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. Mol. Cancer Ther. 2007, 6:173-183.
21. L'Ecuyer T., Allebban Z., Thomas R., Vander Heide R. Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H2057-2064.
22. Lee C.Y., Wey S.P., Liao M.H., Hsu W.L., Wu H.Y., Jan T.R. A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. Int. Immunopharmacol. 2008, 8:732-740.
23. Lerner M. Marihuana: tetrahydrocannabinol and related compounds. Science 1963, 140:175-176.
24. Lu H.R., Zhu H., Huang M., Chen Y., Cai Y.J., Miao Z.H., Zhang J.S., Ding J. Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase. Mol. Pharmacol. 2005, 68:983-994.
25. Massi P., Vaccani A., Bianchessi S., Costa B., Macchi P., Parolaro D. The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell. Mol. Life Sci. 2006, 63:2057-2066.
26. Mates J.M., Segura J.A., Alonso F.J., Marquez J. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch. Toxicol. 2008, 82:273-299.
27. McKallip R.J., Jia W., Schlomer J., Warren J.W., Nagarkatti P.S., Nagarkatti M. Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol. Pharmacol. 2006, 70:897-908.
28. Mechoulam R., Hanus L. Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects. Chem. Phys. Lipids 2002, 121:35-43.
29. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139:271-279.
30. Rajesh M., Mukhopadhyay P., Batkai S., Hasko G., Liaudet L., Drel V.R., Obrosova I.G., Pacher P. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am. J. Physiol. Heart Circ. Physiol. 2007.
31. Rosati E., Sabatini R., Ayroldi E., Tabilio A., Bartoli A., Bruscoli S., Simoncelli C., Rossi R., Marconi P. Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-l-cysteine. J. Leukoc. Biol. 2004, 76:152-161.
32. Starkel P., Sempoux C., Van Den Berge V., Stevens M., De Saeger C., Desager J.P., Horsmans Y. CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin. Life Sci. 1999, 64:643-653.
33. Strasser F., Luftner D., Possinger K., Ernst G., Ruhstaller T., Meissner W., Ko Y.D., Schnelle M., Reif M., Cerny T. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J. Clin. Oncol. 2006, 24:3394-3400.
34. Weiss L., Zeira M., Reich S., Har-Noy M., Mechoulam R., Slavin S., Gallily R. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 2006, 39:143-151.
35. Wu H.Y., Chu R.M., Wang C.C., Lee C.Y., Lin S.H., Jan T.R. Cannabidiol-induced apoptosis in primary lymphocytes is associated with oxidative stress-dependent activation of caspase-8. Toxicol. Appl. Pharmacol. 2008, 226:260-270.
36. Zhang Q.Y., Dunbar D., Kaminsky L.S. Characterization of mouse small intestinal cytochrome P450 expression. Drug Metab. Dispos. 2003, 31:1346-1351.
37. Zuardi A.W., Crippa J.A., Hallak J.E., Moreira F.A., Guimaraes F.S. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz. J. Med. Biol. Res. 2006, 39:421-429.